Texas Biologics Industry Series: Jennifer Leeds
Oct
27
2026
Oct
27
2026
Description
Join Texas Biologics to explore the science and strategy behind bringing new health solutions from discovery through development. Hear from Jennifer Leeds, an accomplished leader in antibacterial drug discovery and biopharmaceutical business development.
-
Seminar: 2 - 3 pm
-
Student Q&A: 3 - 3:30 pm
Jennifer Leeds, Ph.D., owner of JAL Consulting, recently retired from Novartis, where she discovered treatments for Clostridioides difficile infections and a monobactam antibiotic. She also led licensing, investment and business development efforts across the West Coast and Canada.
She serves on the ASM Finance Committee and co-chairs the AAR/Drug Discovery Task Force. Leeds has chaired conferences on antimicrobial R&D and AMR, published 38 research articles and five reviews, authored four book chapters and is an inventor on three patents. She completed postdoctoral training at Harvard Medical School and earned degrees from Cornell University and the University of Wisconsin-Madison.
Location
Norman Hackerman Building Seminar Room, NHB 1.720